Global law firm Norton Rose Fulbright has advised NeOnc Technologies Holdings, Inc. NeOnc on its Memorandum of Understanding (MoU) with the Department of Health – Abu Dhabi DoH concerning the development of research and clinical capability in oncology and central nervous system CNS therapeutics.
The mandate follows Norton Rose Fulbright’s recent advice to NeOnc on its UAE expansion and further demonstrates the firm’s longstanding support for the company as it advances its strategic objectives in the region.
NeOnc is a clinical-stage biopharmaceutical company developing therapies for CNS cancers. The MoU was signed on the sidelines of the Abu Dhabi Future Health Summit 2026.
Under the MoU, NeOnc and DoH will cooperate in areas including the exchange of scientific and clinical knowledge in CNS oncology, clinical development methodologies, real-world evidence and clinical insights. The collaboration extends to training and capacity-building initiatives and the development of Abu Dhabi’s life sciences ecosystem.
The Norton Rose Fulbright team advising NeOnc was led by partner Jonathan Burton, with support from counsel Michael Stevens.
Jonathan Burton said:
“We are delighted to have supported NeOnc on this important collaboration. The MoU brings together NeOnc’s work in CNS cancer therapeutics with Abu Dhabi’s focus on strengthening research and clinical capabilities, with the potential to support further research and innovation in this complex area of healthcare.”
Amir Heshmatpour, Executive Chairman, President & CEO, NeOnc Technologies Holdings, Inc. said:
“We are deeply grateful to the Department of Health – Abu Dhabi for its visionary leadership and commitment to advancing care for patients facing brain cancer. With pediatric patients now enrolled and intranasal administration of our investigational therapy NEO100 underway at Burjeel Hospital in Abu Dhabi, this commitment is already translating into action. This MoU strengthens our shared determination to advance CNS oncology research and bring new hope to children and families facing these devastating diseases.”
Norton Rose Fulbright’s global corporate, M&A and securities practice advises corporations and financial institutions across the full spectrum of industry matters, including joint ventures, public takeovers, private M&A, disposals, debt and equity capital markets, governance, general commercial and corporate advisory matters.
Norton Rose Fulbright:
Norton Rose Fulbright provides a full scope of legal services to the world’s preeminent corporations and financial institutions. The global law firm has more than 3,000 lawyers advising clients across locations in the United States, Europe, Canada, Latin America, Asia, Australia, Africa and the Middle East. With its global business principles of quality, unity and integrity, Norton Rose Fulbright is recognised for its client service in key industries, including financial institutions; energy, infrastructure and resources; technology; transport; life sciences and healthcare; and consumer markets.
CONFIDENTIALITY NOTICE: This email, including any attachments, is confidential and may be privileged. If you are not the intended recipient please notify the sender immediately, and please delete it; you should not copy it or use it for any purpose or disclose its contents to any other person. Norton Rose Fulbright LLP and its affiliates reserve the right to monitor all email communications through their networks.
Norton Rose Fulbright LLP is a limited liability partnership registered in England and Wales with number OC328697, and is authorised and regulated by the Solicitors Regulation Authority. A list of its members and of the other partners is available at its registered office, 3 More London Riverside, London SE1 2AQ; reference to a partner is to a member or to an employee or consultant with equivalent standing and qualification employed or engaged by Norton Rose Fulbright LLP or any of its affiliates.
Norton Rose Fulbright LLP, Norton Rose Fulbright Canada LLP and Norton Rose Fulbright US LLP are separate legal entities and all of them are members of Norton Rose Fulbright Verein, a Swiss verein. Norton Rose Fulbright Verein helps coordinate the activities of the members but does not itself provide legal services to clients. Details of each entity, with certain regulatory information, are available at nortonrosefulbright.com/legal-notices.
